Advancing Gene Therapy Vectors: The Role of scAAVengr Platform in Proprietary AAV Vector Generation
Time: 2:00 pm
day: Day One 11th
Details:
- Discussing the utilization of library approaches to generate diverse vector variants aimed at enhancing delivery efficiency and specificity within the eye
- Exploring how the computationally guided scAAVengr platform facilitates the identification of optimal vector candidates with enhanced infectivity and celltype specificity crucial for effective treatment outcomes
- Discovering how machine learning algorithms facilitate the interpretation of complex data sets, enabling the identification of key vector characteristics correlated with superior performance in ophthalmic gene therapy